BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cipla
Moodys
Baxter
Queensland Health
McKinsey
Teva
McKesson
Fish and Richardson
Covington

Generated: January 22, 2018

DrugPatentWatch Database Preview

NITROPRESS Drug Profile

« Back to Dashboard

When do Nitropress patents expire, and what generic alternatives are available?

Nitropress is a drug marketed by Abbott, Abbvie, and Hospira. and is included in four NDAs.

The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand four hundred and fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Drug patent expirations by year for NITROPRESS
Pharmacology for NITROPRESS
Drug ClassVasodilator
Physiological EffectVasodilation

US Patents and Regulatory Information for NITROPRESS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071555-001 Nov 16, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 070566-001 Jun 9, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abbvie NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 018450-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira NITROPRESS sodium nitroprusside INJECTABLE;INJECTION 071961-001 Aug 1, 1988 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Fuji
Queensland Health
UBS
Novartis
Federal Trade Commission
US Department of Justice
Citi
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot